In the past week, SXTP stock has gone up by 3.35%, with a monthly decline of -22.08% and a quarterly plunge of -16.41%. The volatility ratio for the week is 9.70%, and the volatility levels for the last 30 days are 14.48% for 60 Degrees Pharmaceuticals Inc The simple moving average for the past 20 days is -3.02% for SXTP’s stock, with a -47.08% simple moving average for the past 200 days.
Is It Worth Investing in 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Right Now?
The 36-month beta value for SXTP is also noteworthy at 2.63. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for SXTP is 1.38M, and at present, short sellers hold a 2.07% of that float. The average trading volume of SXTP on May 19, 2025 was 1.58M shares.
SXTP) stock’s latest price update
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) has experienced a rise in its stock price by 14.88 compared to its previous closing price of 2.15. However, the company has seen a gain of 3.35% in its stock price over the last five trading days. globenewswire.com reported 2025-05-15 that Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand. Gross profit increased 124% to $90.3 thousand.
SXTP Trading at 6.78% from the 50-Day Moving Average
After a stumble in the market that brought SXTP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -93.14% of loss for the given period.
Volatility was left at 14.48%, however, over the last 30 days, the volatility rate increased by 9.70%, as shares sank -21.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +55.35% upper at present.
During the last 5 trading sessions, SXTP rose by +3.35%, which changed the moving average for the period of 200-days by -75.05% in comparison to the 20-day moving average, which settled at $2.55. In addition, 60 Degrees Pharmaceuticals Inc saw -61.71% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SXTP starting from XU CHERYL, who purchase 6,000 shares at the price of $1.56 back on Dec 13 ’24. After this action, XU CHERYL now owns 52,078 shares of 60 Degrees Pharmaceuticals Inc, valued at $9,375 using the latest closing price.
XU CHERYL, the Director of 60 Degrees Pharmaceuticals Inc, purchase 5,000 shares at $1.82 during a trade that took place back on Dec 12 ’24, which means that XU CHERYL is holding 46,078 shares at $9,125 based on the most recent closing price.
Stock Fundamentals for SXTP
Current profitability levels for the company are sitting at:
- -15.71 for the present operating margin
- 0.4 for the gross margin
The net margin for 60 Degrees Pharmaceuticals Inc stands at -15.65. The total capital return value is set at -2.47. Equity return is now at value -181.43, with -142.93 for asset returns.
Currently, EBITDA for the company is -7.88 million with net debt to EBITDA at 0.34. When we switch over and look at the enterprise to sales, we see a ratio of 0.28. The receivables turnover for the company is 1.34for trailing twelve months and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.13.
Conclusion
In summary, 60 Degrees Pharmaceuticals Inc (SXTP) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
